The disease spectrum of Helicobacter pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer.

By P. Ernst, B. Gold. Annual Review of Microbiology, 2000

623 citations recorded by the source corpus.

Subfields: Immunology, Surgery

View Paper: https://www.semanticscholar.org/paper/abaa17a27ec69732aa60cb818b34931bfe8e9ee0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

1. R. Peek
2. Martin J. Blaser
3. Keith T. Wilson
4. E. Kuipers
5. Lydia E. Wroblewski
6. A. V. van Vliet
7. J. G. Kusters

In Surgery

1. Martin J. Blaser
2. R. Peek
3. Keith T. Wilson
4. E. Kuipers
5. Lydia E. Wroblewski
6. A. V. van Vliet
7. J. G. Kusters

Citations in the corpus

• Pathogenesis of Helicobacter pylori Infection (2006, background): “pylori-positive patients have a 10 to 20% lifetime risk of developing ulcer disease and a 1 to 2% risk of developing distal gastric cancer (168, 331, 338).”
• Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk (2010, background): “fecal-oral or oral-oral mode of transmission (85, 87).”
• Inflammation and cancer (2002, neutral): “Hepatitis C infection in the liver predisposes to liver carcinoma, an increased risk of bladder and colon carcinoma is associated with schistosomiasis, whereas chronic Helicobacter pylori infection is the world's leading cause of stomach cance”
• Helicobacter pylori and gastrointestinal tract adenocarcinomas (2002, background): “pylori is higher in developing countries than in developed countrie”